Gian Life Care Stock Screener | Share Price & Fundamental Analysis
GIANLIFE
Healthcare Service Provider
Share Price BSE
₹6.58
▲
0.04 (0.61%)
As of April 13, 2026, the Gian Life Care share price (BSE: GIANLIFE) is ₹6.58, up 0.61% from the previous close, with shares trading between ₹6.24 and ₹6.58, and a 52-week range of ₹6.03–₹17.26.
Browse GIANLIFE income statement to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Gian Life Care Market Cap
₹6.76 Cr.
GIANLIFE P/E Ratio (TTM)
-7.04
Gian Life Care P/B Ratio
0.36
EPS (TTM)
₹-0.04
Dividend Yield
-
Debt to Equity
0.28
GIANLIFE 52 Week High
₹17.26
Gian Life Care 52 Week Low
₹6.03
Operating Margin
21.00%
Profit Margin
-
GIANLIFE Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹36.00
Total Equity
₹19.00
Gian Life Care Share Price History - Stock Screener Chart
Screen GIANLIFE historical share price movements with interactive charts. Analyze price trends and patterns.
Gian Life Care Company Profile - Fundamental Screener
Screen Gian Life Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GIANLIFE shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE063601012
Gian Life Care Balance Sheet Screener
Screen GIANLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 36 | 33 | 28 | 23 |
| Current Assets | 18 | 13 | 12 | 10 |
| Fixed Assets | 4 | 5 | 5 | 4 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 3 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 19 | 19 | 15 | 14 |
| Share Capital | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 9 | 9 | 5 | 4 |
Gian Life Care Income Statement Screener - Profit & Revenue Analysis
Screen Gian Life Care income statement and profit fundamentals.
Analyze GIANLIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Gian Life Care share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 4 | 2 | 3 | 2 | 5 | 3 | 3 |
| Expenses | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 |
| EBITDA | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 2 | 1 | 1 | -1 | 2 | 1 | 0 |
| Operating Profit % | 21.00% | -62.00% | 16.00% | -1.00% | 30.00% | 11.00% | 11.00% | 66.00% | 58.00% | 14.00% | 21.00% | -49.00% | 45.00% | 15.00% | -4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 0 | -1 | 0 | 0 | 0 | 3 | 2 | 0 | 0 | -1 | 2 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -1 | 0 | -1 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | -1 | 2 | 1 | 0 |
| EPS | 0.10 | -0.50 | 0.05 | -0.59 | 0.34 | 0.12 | 0.09 | 2.07 | 1.50 | 0.20 | 0.25 | -0.92 | 1.80 | 0.44 | 0.00 |
Gian Life Care Cash Flow Screener - Liquidity Fundamentals
Screen GIANLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 0 | 1 | 2 | 6 |
| Investing Activities | 0 | 0 | -1 | -4 |
| Financing Activities | 0 | 0 | 0 | 1 |
| Net Cash Flow | 1 | 0 | 1 | 2 |
Gian Life Care Shareholding Pattern Screener
See Gian Life Care shareholding pattern with promoter, FII, and DII holdings.
Check Gian Life Care promoter holding and ownership changes for GIANLIFE on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.09% | 32.09% | 32.09% | 32.09% | 32.09% | 31.99% | 32.82% | 48.47% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| Public Holding | 54.05% | 54.15% | 57.96% | 57.72% | 57.66% | 56.62% | 56.34% | 40.36% |
| Other Holding | 13.85% | 13.75% | 9.93% | 10.17% | 10.24% | 11.39% | 10.84% | 11.18% |
| Shareholder Count | 4,217 | 4,285 | 4,363 | 4,382 | 4,298 | 3,863 | 3,349 | 2,426 |
Gian Life Care Share Dividend Screener - Share Yield Analysis
Check Gian Life Care dividend history with payout and yield data.
View Gian Life Care dividend details including ex-dates and amounts for GIANLIFE stock.
Gian Life Care Stock Index Membership
See which indices include Gian Life Care stock.
Check GIANLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Gian Life Care Market Events Screener - Corporate Actions
Get Gian Life Care corporate actions including splits, bonuses, and buybacks.
Check Gian Life Care stock events that may affect GIANLIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.49% | ||
| Annual General Meeting | NA | -4.18% | ||
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -6.94% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -3.09% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.72% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.72% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.58% |
| 2022-03-29 | 2022-03-30 | Bonus | 6:5 | 1.30% |
Gian Life Care Competitors Screener - Peer Comparison
Screen GIANLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,536 | 43.86 | 2,555 | 11.28% | 492 | 60.71 |
| Vijaya Diagnostic Centre | 10,102 | 62.74 | 700 | 23.06% | 144 | 62.23 |
| Metropolis Healthcare | 9,705 | 56.01 | 1,346 | 10.64% | 146 | 58.88 |
| Thyrocare Technologies | 6,351 | 45.95 | 702 | 20.80% | 91 | 60.09 |
| Nephrocare Health Services | 5,622 | 77.63 | 770 | 33.97% | 67 | 56.24 |
| Krsnaa Diagnostics | 1,933 | 24.00 | 743 | 16.70% | 78 | 50.38 |
| Suraksha Diagnostic | 1,433 | 41.99 | 256 | 15.11% | 31 | 60.86 |
| One Global Service Provider | 1,165 | 17.94 | 148 | 134.60% | 19 | 52.94 |
| 3B BlackBio DX | 1,045 | 17.73 | 112 | 28.72% | 48 | 44.85 |
| Sastasundar Ventures | 856 | 29.59 | 1,171 | -18.47% | -134 | 43.80 |
Gian Life Care Company Announcements - News Screener
Screen GIANLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-04 | Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Approval To Enter Into Hospital Lab Management Services With M/S. Brahma Hospital (HUF) | - |
| 2026-02-14 | Outcome Of Board Meeting Held On Saturday February 14 2026 | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 | - |
| 2026-02-09 | Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended On 31St December 2025 | - |
| 2026-01-28 | Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Half Year Ended 30Th September 2025 | - |
| 2026-01-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday January 28 2026 | - |
| 2026-01-24 | Board Meeting Intimation for Rescheduling Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 30Th September 2025 | - |
| 2026-01-21 | Board Meeting Intimation for Rescheduling Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 30Th September 2025 | - |
| 2026-01-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-15 | Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 30Th September 2025 And 31St December 2025 | - |
| 2025-10-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-06 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-10-04 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-10-04 | Proceedings Of AGM | - |
| 2025-09-10 | Reg. 34 (1) Annual Report. | - |
| 2025-09-10 | Shareholders Meeting On September 30 2025 | - |
| 2025-09-02 | Results For Quarter Ended June 30 2025 | - |
| 2025-09-02 | Results For Financial Year 01/04/2024-31/03/2025 | - |
| 2025-09-02 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 14 2025 | - |
| 2025-08-07 | Update on board meeting | - |